img

Global Rasagiline Tablet Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rasagiline Tablet Market Research Report 2024

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases.
According to Mr Accuracy reports’s new survey, global Rasagiline Tablet market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rasagiline Tablet market research.
The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identified it as a potential drug for Parkinson's disease, and working with collaborators at Technion – Israel Institute of Technology in Israel and the drug company, Teva Pharmaceutical, identified the R-isomer as the active form of the drug. Teva brought it to market in partnership with Lundbeck in Europe and Eisai in the US and elsewhere. It was approved in Europe in 2005 and in the US in 2006.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rasagiline Tablet market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Teva Pharmaceutical
Lundbeck
Sun Pharmaceutical
Apotex
Taj Pharma
Mylan
Takeda Pharmaceutical
Sandoz
Intas Pharmaceuticals
Natco Pharma
Ajanta Pharma
Orchid Pharma
Alkem Laboratories
Segment by Type
0.5 mg/Pcs
1 mg/Pcs

Segment by Application


Under 40 Years Old
40-65 Years Old
Above 65 Years Old

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Rasagiline Tablet report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Rasagiline Tablet Market Overview
1.1 Product Overview and Scope of Rasagiline Tablet
1.2 Rasagiline Tablet Segment by Type
1.2.1 Global Rasagiline Tablet Market Value Comparison by Type (2024-2034)
1.2.2 0.5 mg/Pcs
1.2.3 1 mg/Pcs
1.3 Rasagiline Tablet Segment by Application
1.3.1 Global Rasagiline Tablet Market Value by Application: (2024-2034)
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Global Rasagiline Tablet Market Size Estimates and Forecasts
1.4.1 Global Rasagiline Tablet Revenue 2018-2034
1.4.2 Global Rasagiline Tablet Sales 2018-2034
1.4.3 Global Rasagiline Tablet Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Rasagiline Tablet Market Competition by Manufacturers
2.1 Global Rasagiline Tablet Sales Market Share by Manufacturers (2018-2023)
2.2 Global Rasagiline Tablet Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Rasagiline Tablet Average Price by Manufacturers (2018-2023)
2.4 Global Rasagiline Tablet Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Rasagiline Tablet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rasagiline Tablet, Product Type & Application
2.7 Rasagiline Tablet Market Competitive Situation and Trends
2.7.1 Rasagiline Tablet Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rasagiline Tablet Players Market Share by Revenue
2.7.3 Global Rasagiline Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rasagiline Tablet Retrospective Market Scenario by Region
3.1 Global Rasagiline Tablet Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Rasagiline Tablet Global Rasagiline Tablet Sales by Region: 2018-2034
3.2.1 Global Rasagiline Tablet Sales by Region: 2018-2023
3.2.2 Global Rasagiline Tablet Sales by Region: 2024-2034
3.3 Global Rasagiline Tablet Global Rasagiline Tablet Revenue by Region: 2018-2034
3.3.1 Global Rasagiline Tablet Revenue by Region: 2018-2023
3.3.2 Global Rasagiline Tablet Revenue by Region: 2024-2034
3.4 North America Rasagiline Tablet Market Facts & Figures by Country
3.4.1 North America Rasagiline Tablet Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Rasagiline Tablet Sales by Country (2018-2034)
3.4.3 North America Rasagiline Tablet Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Rasagiline Tablet Market Facts & Figures by Country
3.5.1 Europe Rasagiline Tablet Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Rasagiline Tablet Sales by Country (2018-2034)
3.5.3 Europe Rasagiline Tablet Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rasagiline Tablet Market Facts & Figures by Country
3.6.1 Asia Pacific Rasagiline Tablet Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Rasagiline Tablet Sales by Country (2018-2034)
3.6.3 Asia Pacific Rasagiline Tablet Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rasagiline Tablet Market Facts & Figures by Country
3.7.1 Latin America Rasagiline Tablet Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Rasagiline Tablet Sales by Country (2018-2034)
3.7.3 Latin America Rasagiline Tablet Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rasagiline Tablet Market Facts & Figures by Country
3.8.1 Middle East and Africa Rasagiline Tablet Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Rasagiline Tablet Sales by Country (2018-2034)
3.8.3 Middle East and Africa Rasagiline Tablet Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rasagiline Tablet Sales by Type (2018-2034)
4.1.1 Global Rasagiline Tablet Sales by Type (2018-2023)
4.1.2 Global Rasagiline Tablet Sales by Type (2024-2034)
4.1.3 Global Rasagiline Tablet Sales Market Share by Type (2018-2034)
4.2 Global Rasagiline Tablet Revenue by Type (2018-2034)
4.2.1 Global Rasagiline Tablet Revenue by Type (2018-2023)
4.2.2 Global Rasagiline Tablet Revenue by Type (2024-2034)
4.2.3 Global Rasagiline Tablet Revenue Market Share by Type (2018-2034)
4.3 Global Rasagiline Tablet Price by Type (2018-2034)
5 Segment by Application
5.1 Global Rasagiline Tablet Sales by Application (2018-2034)
5.1.1 Global Rasagiline Tablet Sales by Application (2018-2023)
5.1.2 Global Rasagiline Tablet Sales by Application (2024-2034)
5.1.3 Global Rasagiline Tablet Sales Market Share by Application (2018-2034)
5.2 Global Rasagiline Tablet Revenue by Application (2018-2034)
5.2.1 Global Rasagiline Tablet Revenue by Application (2018-2023)
5.2.2 Global Rasagiline Tablet Revenue by Application (2024-2034)
5.2.3 Global Rasagiline Tablet Revenue Market Share by Application (2018-2034)
5.3 Global Rasagiline Tablet Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Teva Pharmaceutical
6.1.1 Teva Pharmaceutical Corporation Information
6.1.2 Teva Pharmaceutical Description and Business Overview
6.1.3 Teva Pharmaceutical Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Teva Pharmaceutical Rasagiline Tablet Product Portfolio
6.1.5 Teva Pharmaceutical Recent Developments/Updates
6.2 Lundbeck
6.2.1 Lundbeck Corporation Information
6.2.2 Lundbeck Description and Business Overview
6.2.3 Lundbeck Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Lundbeck Rasagiline Tablet Product Portfolio
6.2.5 Lundbeck Recent Developments/Updates
6.3 Sun Pharmaceutical
6.3.1 Sun Pharmaceutical Corporation Information
6.3.2 Sun Pharmaceutical Description and Business Overview
6.3.3 Sun Pharmaceutical Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sun Pharmaceutical Rasagiline Tablet Product Portfolio
6.3.5 Sun Pharmaceutical Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Corporation Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Apotex Rasagiline Tablet Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Taj Pharma
6.5.1 Taj Pharma Corporation Information
6.5.2 Taj Pharma Description and Business Overview
6.5.3 Taj Pharma Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Taj Pharma Rasagiline Tablet Product Portfolio
6.5.5 Taj Pharma Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Mylan Rasagiline Tablet Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Takeda Pharmaceutical
6.6.1 Takeda Pharmaceutical Corporation Information
6.6.2 Takeda Pharmaceutical Description and Business Overview
6.6.3 Takeda Pharmaceutical Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Takeda Pharmaceutical Rasagiline Tablet Product Portfolio
6.7.5 Takeda Pharmaceutical Recent Developments/Updates
6.8 Sandoz
6.8.1 Sandoz Corporation Information
6.8.2 Sandoz Description and Business Overview
6.8.3 Sandoz Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sandoz Rasagiline Tablet Product Portfolio
6.8.5 Sandoz Recent Developments/Updates
6.9 Intas Pharmaceuticals
6.9.1 Intas Pharmaceuticals Corporation Information
6.9.2 Intas Pharmaceuticals Description and Business Overview
6.9.3 Intas Pharmaceuticals Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Intas Pharmaceuticals Rasagiline Tablet Product Portfolio
6.9.5 Intas Pharmaceuticals Recent Developments/Updates
6.10 Natco Pharma
6.10.1 Natco Pharma Corporation Information
6.10.2 Natco Pharma Description and Business Overview
6.10.3 Natco Pharma Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Natco Pharma Rasagiline Tablet Product Portfolio
6.10.5 Natco Pharma Recent Developments/Updates
6.11 Ajanta Pharma
6.11.1 Ajanta Pharma Corporation Information
6.11.2 Ajanta Pharma Rasagiline Tablet Description and Business Overview
6.11.3 Ajanta Pharma Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Ajanta Pharma Rasagiline Tablet Product Portfolio
6.11.5 Ajanta Pharma Recent Developments/Updates
6.12 Orchid Pharma
6.12.1 Orchid Pharma Corporation Information
6.12.2 Orchid Pharma Rasagiline Tablet Description and Business Overview
6.12.3 Orchid Pharma Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Orchid Pharma Rasagiline Tablet Product Portfolio
6.12.5 Orchid Pharma Recent Developments/Updates
6.13 Alkem Laboratories
6.13.1 Alkem Laboratories Corporation Information
6.13.2 Alkem Laboratories Rasagiline Tablet Description and Business Overview
6.13.3 Alkem Laboratories Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Alkem Laboratories Rasagiline Tablet Product Portfolio
6.13.5 Alkem Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rasagiline Tablet Industry Chain Analysis
7.2 Rasagiline Tablet Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rasagiline Tablet Production Mode & Process
7.4 Rasagiline Tablet Sales and Marketing
7.4.1 Rasagiline Tablet Sales Channels
7.4.2 Rasagiline Tablet Distributors
7.5 Rasagiline Tablet Customers
8 Rasagiline Tablet Market Dynamics
8.1 Rasagiline Tablet Industry Trends
8.2 Rasagiline Tablet Market Drivers
8.3 Rasagiline Tablet Market Challenges
8.4 Rasagiline Tablet Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Rasagiline Tablet Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Rasagiline Tablet Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Rasagiline Tablet Market Competitive Situation by Manufacturers in 2024
Table 4. Global Rasagiline Tablet Sales (M Pcs) of Key Manufacturers (2018-2023)
Table 5. Global Rasagiline Tablet Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Rasagiline Tablet Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Rasagiline Tablet Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Rasagiline Tablet Average Price (USD/K Pcs) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Rasagiline Tablet, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Rasagiline Tablet, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rasagiline Tablet, Product Type & Application
Table 12. Global Key Manufacturers of Rasagiline Tablet, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rasagiline Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rasagiline Tablet as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rasagiline Tablet Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Rasagiline Tablet Sales by Region (2018-2023) & (M Pcs)
Table 18. Global Rasagiline Tablet Sales Market Share by Region (2018-2023)
Table 19. Global Rasagiline Tablet Sales by Region (2024-2034) & (M Pcs)
Table 20. Global Rasagiline Tablet Sales Market Share by Region (2024-2034)
Table 21. Global Rasagiline Tablet Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Rasagiline Tablet Revenue Market Share by Region (2018-2023)
Table 23. Global Rasagiline Tablet Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Rasagiline Tablet Revenue Market Share by Region (2024-2034)
Table 25. North America Rasagiline Tablet Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Rasagiline Tablet Sales by Country (2018-2023) & (M Pcs)
Table 27. North America Rasagiline Tablet Sales by Country (2024-2034) & (M Pcs)
Table 28. North America Rasagiline Tablet Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Rasagiline Tablet Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Rasagiline Tablet Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Rasagiline Tablet Sales by Country (2018-2023) & (M Pcs)
Table 32. Europe Rasagiline Tablet Sales by Country (2024-2034) & (M Pcs)
Table 33. Europe Rasagiline Tablet Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Rasagiline Tablet Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Rasagiline Tablet Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Rasagiline Tablet Sales by Region (2018-2023) & (M Pcs)
Table 37. Asia Pacific Rasagiline Tablet Sales by Region (2024-2034) & (M Pcs)
Table 38. Asia Pacific Rasagiline Tablet Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Rasagiline Tablet Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Rasagiline Tablet Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Rasagiline Tablet Sales by Country (2018-2023) & (M Pcs)
Table 42. Latin America Rasagiline Tablet Sales by Country (2024-2034) & (M Pcs)
Table 43. Latin America Rasagiline Tablet Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Rasagiline Tablet Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Rasagiline Tablet Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Rasagiline Tablet Sales by Country (2018-2023) & (M Pcs)
Table 47. Middle East & Africa Rasagiline Tablet Sales by Country (2024-2034) & (M Pcs)
Table 48. Middle East & Africa Rasagiline Tablet Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Rasagiline Tablet Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Rasagiline Tablet Sales (M Pcs) by Type (2018-2023)
Table 51. Global Rasagiline Tablet Sales (M Pcs) by Type (2024-2034)
Table 52. Global Rasagiline Tablet Sales Market Share by Type (2018-2023)
Table 53. Global Rasagiline Tablet Sales Market Share by Type (2024-2034)
Table 54. Global Rasagiline Tablet Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Rasagiline Tablet Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Rasagiline Tablet Revenue Market Share by Type (2018-2023)
Table 57. Global Rasagiline Tablet Revenue Market Share by Type (2024-2034)
Table 58. Global Rasagiline Tablet Price (USD/K Pcs) by Type (2018-2023)
Table 59. Global Rasagiline Tablet Price (USD/K Pcs) by Type (2024-2034)
Table 60. Global Rasagiline Tablet Sales (M Pcs) by Application (2018-2023)
Table 61. Global Rasagiline Tablet Sales (M Pcs) by Application (2024-2034)
Table 62. Global Rasagiline Tablet Sales Market Share by Application (2018-2023)
Table 63. Global Rasagiline Tablet Sales Market Share by Application (2024-2034)
Table 64. Global Rasagiline Tablet Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Rasagiline Tablet Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Rasagiline Tablet Revenue Market Share by Application (2018-2023)
Table 67. Global Rasagiline Tablet Revenue Market Share by Application (2024-2034)
Table 68. Global Rasagiline Tablet Price (USD/K Pcs) by Application (2018-2023)
Table 69. Global Rasagiline Tablet Price (USD/K Pcs) by Application (2024-2034)
Table 70. Teva Pharmaceutical Corporation Information
Table 71. Teva Pharmaceutical Description and Business Overview
Table 72. Teva Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 73. Teva Pharmaceutical Rasagiline Tablet Product
Table 74. Teva Pharmaceutical Recent Developments/Updates
Table 75. Lundbeck Corporation Information
Table 76. Lundbeck Description and Business Overview
Table 77. Lundbeck Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 78. Lundbeck Rasagiline Tablet Product
Table 79. Lundbeck Recent Developments/Updates
Table 80. Sun Pharmaceutical Corporation Information
Table 81. Sun Pharmaceutical Description and Business Overview
Table 82. Sun Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 83. Sun Pharmaceutical Rasagiline Tablet Product
Table 84. Sun Pharmaceutical Recent Developments/Updates
Table 85. Apotex Corporation Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 88. Apotex Rasagiline Tablet Product
Table 89. Apotex Recent Developments/Updates
Table 90. Taj Pharma Corporation Information
Table 91. Taj Pharma Description and Business Overview
Table 92. Taj Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 93. Taj Pharma Rasagiline Tablet Product
Table 94. Taj Pharma Recent Developments/Updates
Table 95. Mylan Corporation Information
Table 96. Mylan Description and Business Overview
Table 97. Mylan Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 98. Mylan Rasagiline Tablet Product
Table 99. Mylan Recent Developments/Updates
Table 100. Takeda Pharmaceutical Corporation Information
Table 101. Takeda Pharmaceutical Description and Business Overview
Table 102. Takeda Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 103. Takeda Pharmaceutical Rasagiline Tablet Product
Table 104. Takeda Pharmaceutical Recent Developments/Updates
Table 105. Sandoz Corporation Information
Table 106. Sandoz Description and Business Overview
Table 107. Sandoz Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 108. Sandoz Rasagiline Tablet Product
Table 109. Sandoz Recent Developments/Updates
Table 110. Intas Pharmaceuticals Corporation Information
Table 111. Intas Pharmaceuticals Description and Business Overview
Table 112. Intas Pharmaceuticals Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 113. Intas Pharmaceuticals Rasagiline Tablet Product
Table 114. Intas Pharmaceuticals Recent Developments/Updates
Table 115. Natco Pharma Corporation Information
Table 116. Natco Pharma Description and Business Overview
Table 117. Natco Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 118. Natco Pharma Rasagiline Tablet Product
Table 119. Natco Pharma Recent Developments/Updates
Table 120. Ajanta Pharma Corporation Information
Table 121. Ajanta Pharma Description and Business Overview
Table 122. Ajanta Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 123. Ajanta Pharma Rasagiline Tablet Product
Table 124. Ajanta Pharma Recent Developments/Updates
Table 125. Orchid Pharma Corporation Information
Table 126. Orchid Pharma Description and Business Overview
Table 127. Orchid Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 128. Orchid Pharma Rasagiline Tablet Product
Table 129. Orchid Pharma Recent Developments/Updates
Table 130. Alkem Laboratories Corporation Information
Table 131. Alkem Laboratories Description and Business Overview
Table 132. Alkem Laboratories Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 133. Alkem Laboratories Rasagiline Tablet Product
Table 134. Alkem Laboratories Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Rasagiline Tablet Distributors List
Table 138. Rasagiline Tablet Customers List
Table 139. Rasagiline Tablet Market Trends
Table 140. Rasagiline Tablet Market Drivers
Table 141. Rasagiline Tablet Market Challenges
Table 142. Rasagiline Tablet Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Rasagiline Tablet
Figure 2. Global Rasagiline Tablet Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Rasagiline Tablet Market Share by Type in 2024 & 2034
Figure 4. 0.5 mg/Pcs Product Picture
Figure 5. 1 mg/Pcs Product Picture
Figure 6. Global Rasagiline Tablet Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Rasagiline Tablet Market Share by Application in 2024 & 2034
Figure 8. Under 40 Years Old
Figure 9. 40-65 Years Old
Figure 10. Above 65 Years Old
Figure 11. Global Rasagiline Tablet Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Rasagiline Tablet Market Size (2018-2034) & (US$ Million)
Figure 13. Global Rasagiline Tablet Sales (2018-2034) & (M Pcs)
Figure 14. Global Rasagiline Tablet Average Price (USD/K Pcs) & (2018-2034)
Figure 15. Rasagiline Tablet Report Years Considered
Figure 16. Rasagiline Tablet Sales Share by Manufacturers in 2024
Figure 17. Global Rasagiline Tablet Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest Rasagiline Tablet Players: Market Share by Revenue in 2024
Figure 19. Rasagiline Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 20. Global Rasagiline Tablet Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 21. North America Rasagiline Tablet Sales Market Share by Country (2018-2034)
Figure 22. North America Rasagiline Tablet Revenue Market Share by Country (2018-2034)
Figure 23. U.S. Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Rasagiline Tablet Sales Market Share by Country (2018-2034)
Figure 26. Europe Rasagiline Tablet Revenue Market Share by Country (2018-2034)
Figure 27. Germany Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Rasagiline Tablet Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Rasagiline Tablet Revenue Market Share by Region (2018-2034)
Figure 34. China Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. China Taiwan Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America Rasagiline Tablet Sales Market Share by Country (2018-2034)
Figure 44. Latin America Rasagiline Tablet Revenue Market Share by Country (2018-2034)
Figure 45. Mexico Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Rasagiline Tablet Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa Rasagiline Tablet Revenue Market Share by Country (2018-2034)
Figure 50. Turkey Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. UAE Rasagiline Tablet Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Rasagiline Tablet by Type (2018-2034)
Figure 54. Global Revenue Market Share of Rasagiline Tablet by Type (2018-2034)
Figure 55. Global Rasagiline Tablet Price (USD/K Pcs) by Type (2018-2034)
Figure 56. Global Sales Market Share of Rasagiline Tablet by Application (2018-2034)
Figure 57. Global Revenue Market Share of Rasagiline Tablet by Application (2018-2034)
Figure 58. Global Rasagiline Tablet Price (USD/K Pcs) by Application (2018-2034)
Figure 59. Rasagiline Tablet Value Chain
Figure 60. Rasagiline Tablet Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed